Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2021-02-09 Major Shareholding Noti…
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
SC 13G/A
Major Shareholding Notification
2021-02-09 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-08 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-05 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1462 characters), and it primarily serves as a regulatory filing to report information to the SEC. There is no indication that this is a full annual report, earnings release, or other detailed financial report. According to the rules, Form 6-K filings are typically classified as Regulatory Filings (RNS) unless they contain full financial reports, which this does not. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-01-05 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data itself. The document length is short (1467 characters), and it primarily serves as a regulatory filing to report information to the SEC. According to the rules, such filings that do not contain full financial reports or detailed data but serve as regulatory announcements should be classified as Regulatory Filings (RNS).
2020-12-21 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It is a short filing (1467 characters) that primarily serves as a cover report indicating the submission of an attached press release dated November 30, 2020. There is no substantive financial data or detailed report content within this text itself. According to the 'Menu vs Meal' rule, such a short filing that references an attached document is classified as a Regulatory Filing (RNS), as it does not contain the full report or detailed financial information but rather announces or submits a related document.
2020-11-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.